Literature DB >> 8416975

Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame.

J R Hill1, D R Morris.   

Abstract

The mRNA encoding S-adenosylmethionine decarboxylase (AdoMetDC) has a 330-nucleotide 5'-transcript leader containing an open reading frame (uORF) that codes for the hexapeptide MAGDIS. The uORF restricts the intracellular distribution of AdoMetDC mRNA primarily to monosomes in normal T-lymphocytes and in T-cell lines. In contrast, non-lymphoid cells normally carry an average of seven to nine ribosomes per AdoMetDC mRNA molecule (Hill, J.R., and Morris, D. R. (1992) J. Biol. Chem. 267, 21886-21893). Several alterations abolish the negative regulatory effect of the uORF in T-cells. These include removing the site of translational initiation; weakening the context of the translational initiation site; changing the coding capacity of the fourth, fifth, and sixth codons; increasing the length of the uORF at either the 5' or 3' end; or changing the primary order of the codons. In contrast, altering the nucleic acid sequence of the uORF at degenerative positions without changing the amino acid coding capacity did not cause deregulation. The uORF does not regulate translation in the trans-configuration. Our results support a model in which translation of the uORF generates a nascent hexapeptide that interacts with its translating ribosome to suppress translation of AdoMetDC mRNA in a cell-specific manner. Structural features of the carboxyl-terminal 3 amino acids of the putative hexapeptide govern the interaction of the peptide with a component of the translation machinery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Upstream open reading frames as regulators of mRNA translation.

Authors:  D R Morris; A P Geballe
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Termination and peptide release at the upstream open reading frame are required for downstream translation on synthetic shunt-competent mRNA leaders.

Authors:  M Hemmings-Mieszczak; T Hohn; T Preiss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  The major open reading frame of the beta2.7 transcript of human cytomegalovirus: in vitro expression of a protein posttranscriptionally regulated by the 5' region.

Authors:  G Bergamini; M Reschke; M C Battista; M C Boccuni; F Campanini; A Ripalti; M P Landini
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 5.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

Review 6.  Ribosome regulation by the nascent peptide.

Authors:  P S Lovett; E J Rogers
Journal:  Microbiol Rev       Date:  1996-06

7.  Inhibition of nascent-peptide release at translation termination.

Authors:  J Cao; A P Geballe
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

8.  Baculovirus gp64 gene expression: negative regulation by a minicistron.

Authors:  M J Chang; G W Blissard
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  Preferential Ribosome Loading on the Stress-Upregulated mRNA Pool Shapes the Selective Translation under Stress Conditions.

Authors:  Yan Chen; Min Liu; Zhicheng Dong
Journal:  Plants (Basel)       Date:  2021-02-05

10.  Molecular and biochemical characterization of S-adenosylmethionine decarboxylase from the free-living nematode Caenorhabditis elegans.

Authors:  A A Da'dara; R D Walter
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.